Inventor
CONCINO MICHAEL F
US21 patents
⚠️ This page may combine multiple inventors who share the name “CONCINO MICHAEL F”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SHIRE HUMAN GENETIC THERAPIES
9 patentsUS9814764B2Nov 14, 2017
Treatment of sanfilippo syndrome type b by intrathecal administration of alpha-n-acetylglucosaminidase
SHIRE HUMAN GENETIC THERAPIES9 citations90
US10556015B2Feb 11, 2020
Lysosomal targeting of enzymes, and uses thereof
SHIRE HUMAN GENETIC THERAPIES7 citations83
US11065307B2Jul 20, 2021
Therapeutic fusion protein comprising an alpha-n-acetylglucosaminidase and a lysosomal targeting moiety
SHIRE HUMAN GENETIC THERAPIES2 citations81
US10603364B2Mar 31, 2020
Lysosomal targeting and uses thereof
SHIRE HUMAN GENETIC THERAPIES2 citations70
US10722559B2Jul 28, 2020
Mannose-6-phosphate bearing peptides fused to lysosomal enzymes
SHIRE HUMAN GENETIC THERAPIES5 citations68
US10729746B2Aug 4, 2020
Recombinant placenta growth factor for treating Duchenne muscular dystrophy
SHIRE HUMAN GENETIC THERAPIES0 citations49
US9708590B2Jul 18, 2017
Crystal structure of human α-N-acetylglucosaminidase
SHIRE HUMAN GENETIC THERAPIES0 citations49
US7229793B1Jun 12, 2007
Constructs and cells for production of small peptides
SHIRE HUMAN GENETIC THERAPIES1 citations48
US9597376B2Mar 21, 2017
Lipoprotein lipase for treatment of hypertriglyceridemic-related conditions including acute pancreatitis
SHIRE HUMAN GENETIC THERAPIES0 citations43
UNIV JOHNS HOPKINS
5 patentsUS5981481ANov 9, 1999
Human C3b/C4b receptor (CR1)
UNIV JOHNS HOPKINS80 citations95
US5856297AJan 5, 1999
Human C3b/C4b receptor (CR1)
UNIV JOHNS HOPKINS58 citations95
US5472939ADec 5, 1995
Method of treating complement mediated disorders
UNIV JOHNS HOPKINS70 citations95
US5256642AOct 26, 1993
Compositions of soluble complement receptor 1 (CR1) and a thrombolytic agent, and the methods of use thereof
UNIV JOHNS HOPKINS49 citations95
US5212071AMay 18, 1993
Nucleic acids encoding a human C3b/C4b receptor (CR1)
UNIV JOHNS HOPKINS100 citations95
TRANSKARYOTIC THERAPIES INC
4 patentsUS5817789AOct 6, 1998
Chimeric proteins for use in transport of a selected substance into cells
TRANSKARYOTIC THERAPIES INC99 citations98
US6262026B1Jul 17, 2001
Chimeric proteins for use in transport of a selected substance into cells
TRANSKARYOTIC THERAPIES INC52 citations95
US6027921AFeb 22, 2000
Chimeric proteins for use in transport of a selected substance into cells and DNA encoding chimeric proteins
TRANSKARYOTIC THERAPIES INC69 citations95
US6858578B2Feb 22, 2005
Chimeric proteins for use in transport of a selected substance into cells
TRANSKARYOTIC THERAPIES INC10 citations73